5-chloro-2-(difluoromethoxy)toluene | 639826-17-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 5-chloro-2-(difluoromethoxy)toluene
• 英文别名: 4-Chloro-1-(difluoromethoxy)-2-methylbenzene
• CAS: 639826-17-8
• 化学式: C₈H₇ClF₂O
• mdl: MFCD11106724
• 分子量: 192.593
• InChiKey: CIJOHDFSCNTPPE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Esters of 2-phenylalkanenitriles and antifungal compositions containing them
  申请人：Stoutamire Donald Wesley

  公开号：US20080153905A1

  公开（公告）日：2008-06-26

  Esters of 2-phenylalkanenitriles, such as 3-acetoxy-2-(2-chloro-5-(difluoromethoxy)phenyl)propanenitrile and 3-acetoxy-2-(4-chlorophenyl)propanenitrile, and compositions containing such esters, are useful as fungicides at very low concentrations.

  2-苯基烷基腈的酯，如3-乙氧基-2-(2-氯-5-(二氟甲氧基)苯基)丙腈和3-乙氧基-2-(4-氯苯基)丙腈，以及含有这些酯的组合物，在极低浓度下作为杀真菌剂是有用的。
• [EN] TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TNF<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES TRICYCLIQUES UTILES COMME INHIBITEURS DU TNF
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2016149437A1

  公开（公告）日：2016-09-22

  Disclosed are compounds of Formula (I) or a salt thereof, wherein: X is N; W is: -(CR3R3)2-5-, -(CR3R3)x-Y-(CR3R3)y-, -Y-(CR3R3)2-3-Y-, -CR3R3-Y-(CR3R3)2-Y-,-Y-(CR3R3)2-Y-CR3R3-; and Y, R1, R2, R3, R5, R6, R8, x, and y are define herein. Also disclosed are methods of using such compounds as modulators of TNFα, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

  本发明涉及公式(I)化合物或其盐，其中：X为N; W为：-(CR3R3)2-5-，-(CR3R3)x-Y-(CR3R3)y-，-Y-(CR3R3)2-3-Y-，-CR3R3-Y-(CR3R3)2-Y-，-Y-(CR3R3)2-Y-CR3R3-; Y、R1、R2、R3、R5、R6、R8、x和y的定义如本文所述。此外，本发明还涉及将这些化合物用作TNFα调节剂的方法，以及包含这些化合物的药物组合物。这些化合物在治疗炎症和自身免疫性疾病方面具有用途。
• ESTERS OF 2-PHENYLALKANENITRILES AND ANTIFUNGAL COMPOSITIONS CONTAINING THEM
  申请人：Stoutamire Donald Wesley

  公开号：US20100022640A1

  公开（公告）日：2010-01-28

  Esters of 2-phenylalkanenitriles, such as 3-acetoxy-2-(2-chloro-5-(difluoromethoxy)phenyl)propanenitrile and 3-acetoxy-2-(4-chlorophenyl)propanenitrile, and compositions containing such esters, are useful as fungicides at very low concentrations.

  2-苯基烷腈酯，例如3-乙酰氧基-2-(2-氯-5-(二氟甲氧基)苯基)丙腈和3-乙酰氧基-2-(4-氯苯基)丙腈，以及含有这些酯的组合物，在非常低的浓度下可用作杀真菌剂。
• PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS
  申请人：Gibbons Paul

  公开号：US20120190665A1

  公开（公告）日：2012-07-26

  A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 and R 3 are defined herein, are useful as inhibitors of one or more Janus kinases. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient are disclosed.

  公式I的化合物、对映异构体、顺反异构体、互变异构体或其药学上可接受的盐，其中R1、R2和R3的定义如本文所述，可用作一种或多种Janus激酶的抑制剂。本文还揭示了一种包括公式I的化合物和药学上可接受的载体、辅料或载体的药物组合物，以及治疗或减轻患者对Janus激酶活性抑制响应的疾病或状况的方法。
• CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS
  申请人：Lam Patrick Y.S.

  公开号：US20140163002A1

  公开（公告）日：2014-06-12

  The present invention provides compounds of Formula (Ia): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.

  本发明提供了式(Ia)的化合物：或其立体异构体、互变异构体或药学上可接受的盐，其中所有变量如本文所定义。这些化合物是选择性因子XIa抑制剂或FXIa和血浆卡利肯双重抑制剂。本发明还涉及包含这些化合物的制药组合物以及使用它们治疗血栓栓塞性和/或炎症性疾病的方法。